Current Molecular Pharmacology (CMP) is at the cutting edge of publishing the latest advancements in cellular and molecular pharmacology. We focus on the mechanisms of action of new drugs under development, innovative pharmacological technologies, and the application of genomics, proteomics, and metabonomics to drug action. The journal also delves into how studying drug actions at the cellular and molecular levels provides insights into normal biological functions, thus deepening our understanding of therapeutic interventions and fundamental biological processes.
With an impact factor of 2.9 in 2025, CMP is extensively indexed in databases such as BIOSIS Previews, Cabell's Directory, Chemical Abstracts, China National Knowledge Infrastructure (CNKI), EBSCOhost, Embase, Essential Science Indicators, Google Scholar, Index Medicus, Medline, PubMed, Science Citation Index Expanded (SCIE), and Scopus. CMP achieves Q2 ranking in the Pharmacology & Pharmacy category .
Contact Us:
CMP Homepage: https://www.keaipublishing.com/en/journals/current-molecular-pharmacology/
For inquiries, please contact: editorial@fargroups.com
Eligibility Criteria
To apply, meet any two of the following criteria:
Responsibilities of Young Editorial Board Members
Development Opportunities
Application Method
Please send your resume to the email address: cmp@fargroups.com